Diagnostic Accuracy of Skin Cancer by Family Physicians

References

1. 1.↵
   1. Vries E

   . Skin conditions at the FP and dermatologist. Available from: https://www.ntvg.nl/academie/infographics/huidaandoeningen-bij-huisarts-en-dermatoloog. Published 2013. Accessed August 28, 2019.
2. 2.↵
   Netherlands Comprehensive Cancer Organisation. Available from: https://www.iknl.nl/kankersoorten/huidkanker. Published 2019. Accessed May 25, 2020.
3. 3.↵
   Netherlands Comprehensive Cancer Organisation. Skin cancer in the Netherlands; figures from 30 years of Dutch cancer registration. Available from: https://iknlsawebprod.blob.core.windows.net/mediacontainer/iknl/media/pdfs/kankersoorten/iknl_huidkanker-in-nl_rapport_nkr.pdf. Published 2019. Accessed May 25, 2020.
4. 4.↵
   Nivel care registration primary care. Incidence and prevalence. Available from: https://www.nivel.nl/nl/nivel-zorgregistraties-eerste-lijn/incidenties-en-prevalenties. Published 2019. Accessed November 28, 2019.
5. 5.↵
   Dutch cancer registration. Skin cancer, figures and context, current. Available from: https://www.volksgezondheidenzorg.info/onderwerp/huidkanker/cijfers-context/huidige-situatie. Published 2019. Accessed October 20, 2019.
6. 6.↵
   1. Goldenberg G,
   2. Karagiannis T,
   3. Palmer JB,
   4. et al

   . Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort study. J Am Acad Dermatol 2016;75:957–966e2.

   OpenUrlCrossRef
7. 7.↵
   1. Carr S,
   2. Smith C,
   3. Wernberg J

   . Epidemiology and risk factors of melanoma. Surg Clin North Am 2020;100:1–12.

   OpenUrlCrossRef
8. 8.↵
   1. Hoorens I,
   2. Vossaert K,
   3. Ongenae K,
   4. Brochez L

   . Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening. Br J Dermatol 2016;174:1258–1265.

   OpenUrl
9. 9.↵
   1. Chen SC,
   2. Bravata DM,
   3. Weil E,
   4. Olkin I

   . A comparison of dermatologists' and primary care physicians' accuracy in diagnosing melanoma: a systematic review. Arch Dermatol 2001;137:1627–1634.

   OpenUrlPubMedWeb of Science
10. 10.↵
    1. Swetter SM,
    2. Chang J,
    3. Shaub AR,
    4. Weinstock MA,
    5. Lewis ET,
    6. Asch SM

    . Primary Care-Based Skin Cancer Screening in a Veterans Affairs Health Care System. JAMA Dermatol 2017;153:797–801.

    OpenUrl
11. 11.↵
    1. Marra E,
    2. van Rijsingen MCJ,
    3. Alkemade JAC,
    4. et al

    . The effect of a dermato-oncological training programme on the diagnostic skills and quality of referrals for suspicious skin lesions by general practitioners. Br J Dermatol 2021;184:538–544.

    OpenUrlPubMed
12. 12.↵
    1. Ahmadi K,
    2. Prickaerts E,
    3. Smeets JGE,
    4. Joosten V,
    5. Kelleners-Smeets NWJ,
    6. Dinant GJ

    . Current approach of skin lesions suspected of malignancy in general practice in the Netherlands: a quantitative overview. J Eur Acad Dermatol Venereol 2018;32:236–241.

    OpenUrl
13. 13.↵
    1. Hofmans-Okkes IM,
    2. Lamberts H

    . The International Classification of Primary Care (ICPC): new applications in research and computer-based patient records in family practice. Fam Pract 1996;13:294–302.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Luijks H,
    2. Van Boven KO,
    3. Hartman T,
    4. Uijen A,
    5. Van Weel C,
    6. Schers H

    . Making visible what is intuitively known by family physicians. Capturing core values of family medicine in structured data. In Press. J Am Board Fam Med 2021.
15. 15.↵
    Oncoline. Dutch Melanoma work group. Available from: https://www.oncoline.nl/melanoom. Published 2012. Accessed November 03, 2020.
16. 16.↵
    MedCalc Software bv. Diagnostic test evaluation calculator: MedCalc Software bv. Available from: https://www.medcalc.org/calc/diagnostic_test.php. Published 2019. Accessed November 20, 2019.
17. 17.↵
    CBS. Population; sex, age and marital status. Available from: https://opendata.cbs.nl/statline/?dl=308BE#/CBS/nl/dataset/7461bev/table. Published 2020. Accessed May 10, 2021.
18. 18.↵
    1. van Rijsingen MC,
    2. Hanssen SC,
    3. Groenewoud JM,
    4. van der Wilt GJ,
    5. Gerritsen MJ

    . Referrals by general practitioners for suspicious skin lesions: the urgency of training. Acta Derm Venereol 2014;94:138–141.

    OpenUrl
19. 19.↵
    1. Leeflang MMG,
    2. Bossuyt PMM,
    3. Irwig L

    . Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis. J Clin Epidemiol 2009;62:5–12.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Leeflang MMG,
    2. Rutjes AWS,
    3. Reitsma JB,
    4. Hooft L,
    5. Bossuyt PMM

    . Variation of a test's sensitivity and specificity with disease prevalence. CMAJ 2013;185:E537–E44.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Verhoeven EW,
    2. Kraaimaat FW,
    3. van Weel C,
    4. et al

    . Skin diseases in family medicine: prevalence and health care use. Ann Fam Med 2008;6:349–54.

    OpenUrlAbstract/FREE Full Text